NCT00392080View on ClinicalTrials.gov

A Study Of The Effect Of CJ-023,423 On The Incidence Of Stomach Ulcers

PHASE1CompletedINTERVENTIONAL
Enrollment

340

Participants

Timeline

Start Date

November 30, 2006

Study Completion Date

February 29, 2008

Conditions
Osteoarthritis
Interventions
DRUG

CJ-023,423

75 mg BID

DRUG

placebo

placebo

DRUG

naproxen

naproxen

Trial Locations (11)

10021

Pfizer Investigational Site, New York

23320

Pfizer Investigational Site, Chesapeake

27607

Pfizer Investigational Site, Raleigh

27612

Pfizer Investigational Site, Raleigh

33143

Pfizer Investigational Site, South Miami

33458

Pfizer Investigational Site, Jupiter

34761

Pfizer Investigational Site, Ocoee

77074

Pfizer Investigational Site, Houston

77090

Pfizer Investigational Site, Houston

92801

Pfizer Investigational Site, Anaheim

92103-6204

Pfizer Investigational Site, San Diego

Sponsors

Lead Sponsor

Pfizer
All Listed Sponsors
lead

Pfizer

INDUSTRY